By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Agilent Technologies and Sage Science today announced a co-marketing deal covering each other's technologies for next-generation sequencing applications.

The deal covers Agilent's 2100 Bioanalyzer for detecting and quantifying nucleic acids and Sage's Pippin Prep DNA size selection system. In addition to co-promoting the platforms, the partners will develop application studies that leverage the combined capabilities of the two systems.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.

A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.